D. Catalán

发表

Multiple imputation procedures allow the rescue of missing data: an application to determine serum tumor necrosis factor (TNF) concentration values during the treatment of rheumatoid arthritis patients with anti-TNF therapy.

R. Villegas, J. Cuenca, J. Aguillón, 2005, Biological research.

Inflammation, synovial angiogenesis and chondroid apoptosis in the evolution of type II collagen-induced arthritis.

J. Aguillón, B. Pesce, L. Salazar, 2007, European cytokine network.

TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patients

M. Menon, J. Aguillón, C. Mauri, 2017, Arthritis Research & Therapy.

The -308 polymorphism in the promoter region of the tumor necrosis factor-alpha (TNF-alpha) gene and ex vivo lipopolysaccharide-induced TNF-alpha expression in patients with aggressive periodontitis and/or type 1 diabetes mellitus.

J. Cuenca, A. Aguirre, Arturo Ferreira, 2004, European cytokine network.

Analysis of the HLA‐DR peptidome from human dendritic cells reveals high affinity repertoires and nonconventional pathways of peptide generation

J. Voorberg, M. Ciudad, A. Meijer, 2017, Journal of leukocyte biology.

Regulation of Tolerogenic Features on Dexamethasone-Modulated MPLA-Activated Dendritic Cells by MYC

Ahmed M. Mehdi, M. Molina, J. Aguillón, 2019, Front. Immunol..

Neuropilin-1 in Transplantation Tolerance

Mauricio Campos-Mora, Rodrigo A. Morales, Karina Pino-Lagos, 2013, Front. Immunol..

An efficient method for variable region assembly in the construction of scFv phage display libraries using independent strand amplification

M. Molina, J. Aguillón, D. Catalán, 2012, mAbs.

Neuropilin‐1+ regulatory T cells promote skin allograft survival and modulate effector CD4+ T cells phenotypic signature

J. Aguillón, Mauricio Campos-Mora, Rodrigo A. Morales, 2015, Immunology and cell biology.

B cell contribution to immunometabolic dysfunction and impaired immune responses in obesity

E. Rosser, D. Catalán, K. Oleinika, 2022, Clinical and experimental immunology.

TNF-α Affects Signature Cytokines of Th1 and Th17 T Cell Subsets through Differential Actions on TNFR1 and TNFR2

J. Aguillón, B. Pesce, D. Catalán, 2022, International journal of molecular sciences.

Modulation of established murine collagen-induced arthritis by a single inoculation of short-term lipopolysaccharide-stimulated dendritic cells

R. Toes, A. Aguirre, A. Escobar, 2007, Annals of the rheumatic diseases.

Short-term lipopolysaccharide stimulation induces differentiation of murine bone marrow-derived dendritic cells into a tolerogenic phenotype.

J. Aguillón, A. Kalergis, M. Iruretagoyena, 2007, European cytokine network.

Tolerogenic dendritic cells for reprogramming of lymphocyte responses in autoimmune diseases.

J. Aguillón, D. Catalán, Paulina A. García-González, 2016, Autoimmunity reviews.

Dexamethasone and Monophosphoryl Lipid A-Modulated Dendritic Cells Promote Antigen-Specific Tolerogenic Properties on Naive and Memory CD4+ T Cells

J. Aguillón, C. Hilkens, B. Pesce, 2016, Front. Immunol..

Basal anti-cyclic citrullinated peptide (anti-CCP) antibody levels and a decrease in anti-CCP titres are associated with clinical response to adalimumab in rheumatoid arthritis.

J. Aguillón, B. Pesce, H. Gatica, 2008, Clinical and experimental rheumatology.

Tumour necrosis factor (TNF)α −308 G/G promoter polymorphism and TNFα levels correlate with a better response to adalimumab in patients with rheumatoid arthritis

J. Aguillón, C. Llanos, F. Salazar-Onfray, 2006 .

Blocking of p38 and transforming growth factor β receptor pathways impairs the ability of tolerogenic dendritic cells to suppress murine arthritis.

M. Molina, J. Aguillón, B. Pesce, 2013, Arthritis and rheumatism.

Dexamethasone Preconditioning Improves the Response of Collagen-Induced Arthritis to Treatment with Short-Term Lipopolysaccharide-Stimulated Collagen-Loaded Dendritic Cells

J. Aguillón, O. Aravena, D. Catalán, 2013, Clinical & developmental immunology.

Dexamethasone and Monophosphoryl Lipid A Induce a Distinctive Profile on Monocyte-Derived Dendritic Cells through Transcriptional Modulation of Genes Associated With Essential Processes of the Immune Response

Ahmed M. Mehdi, M. Molina, J. Aguillón, 2017, Front. Immunol..

The immunological response and post-treatment survival of DC-vaccinated melanoma patients are associated with increased Th1/Th17 and reduced Th3 cytokine responses

B. Nervi, F. Salazar-Onfray, C. Durán-Aniotz, 2013, Cancer Immunology, Immunotherapy.

Isolation of HLA-DR-naturally presented peptides identifies T-cell epitopes for rheumatoid arthritis

J. Aguillón, E. James, M. Carrascal, 2022, Annals of the Rheumatic Diseases.

Treatment with Dexamethasone and Monophosphoryl Lipid A Removes Disease-Associated Transcriptional Signatures in Monocyte-Derived Dendritic Cells from Rheumatoid Arthritis Patients and Confers Tolerogenic Features

Ahmed M. Mehdi, M. Molina, J. Aguillón, 2016, Front. Immunol..

Aguilón JC. Treatment with Dexamethasone and Monophosphoryl Lipid A Removes Disease-Associated Transcriptional Signatures in Monocyte-Derived Dendritic Cells from Rheumatoid Arthritis Patients and Confers Tolerogenic

Ahmed M. Mehdi, M. Molina, J. Aguillón, 2016 .

Immunosuppressive Mechanisms of Regulatory B Cells

J. Aguillón, O. Aravena, D. Catalán, 2021, Frontiers in Immunology.

Microbiota-Derived Metabolites Suppress Arthritis by Amplifying Aryl-Hydrocarbon Receptor Activation in Regulatory B Cells

André F. Rendeiro, S. Eaton, I. Drozdov, 2020, Cell metabolism.

Skewing dendritic cell differentiation towards a tolerogenic state for recovery of tolerance in rheumatoid arthritis.

J. Aguillón, D. Catalán, L. Soto, 2015, Autoimmunity reviews.

Therapeutic Potential of Hyporesponsive CD4+ T Cells in Autoimmunity

J. Aguillón, D. Catalán, J. Maggi, 2015, Front. Immunol..

Tolerogenic Dendritic Cells Derived from Donors with Natural Rubber Latex Allergy Modulate Allergen-Specific T-Cell Responses and IgE Production

Alejandro Escobar, A. Aguirre, A. Escobar, 2014, PloS one.

Anti-TNF therapy in patients with rheumatoid arthritis decreases Th1 and Th17 cell populations and expands IFN-γ-producing NK cell and regulatory T cell subsets.

M. Molina, J. Aguillón, B. Pesce, 2011, Immunobiology.

Systemic Sclerosis Patients Present Alterations in the Expression of Molecules Involved in B-Cell Regulation

A. Biere, J. Aguillón, O. Aravena, 2015, Front. Immunol..

Clinical parameters and biomarkers for anti-TNF treatment prognosis in rheumatoid arthritis patients

J. Aguillón, D. Catalán, M. Cuchacovich, 2014, Clinical Rheumatology.

Effect of interleukin‐6 receptor blockade on the balance between regulatory T cells and T helper type 17 cells in rheumatoid arthritis patients

M. Molina, J. Aguillón, B. Pesce, 2013, Clinical and experimental immunology.

B cells from rheumatoid arthritis patients show important alterations in the expression of CD86 and FcγRIIb, which are modulated by anti-tumor necrosis factor therapy

J. Aguillón, A. Kalergis, O. Aravena, 2010, Arthritis research & therapy.

The role of interleukin‐6 signalling and its therapeutic blockage in skewing the T cell balance in rheumatoid arthritis

J. Aguillón, D. Catalán, L. Soto, 2017, Clinical and experimental immunology.

Rapamycin-conditioned dendritic cells activated with monophosphoryl lipid-A promote allograft acceptance in vivo.

J. Aguillón, Mauricio Campos-Mora, Francisco Pérez, 2015, Immunotherapy.

Clinical significance of tumor expression of major histocompatibility complex class I-related chains A and B (MICA/B) in gastric cancer patients

M. Molina, J. Aguillón, L. Mercado, 2015, Oncology reports.

A short protocol using dexamethasone and monophosphoryl lipid A generates tolerogenic dendritic cells that display a potent migratory capacity to lymphoid chemokines

M. Molina, J. Aguillón, B. Pesce, 2013, Journal of Translational Medicine.

Tumour necrosis factor (TNF)alpha -308 G/G promoter polymorphism and TNFalpha levels correlate with a better response to adalimumab in patients with rheumatoid arthritis.

J. Aguillón, C. Llanos, F. Salazar-Onfray, 2006, Scandinavian journal of rheumatology.

The presence of anti-citrullinated protein antibodies (ACPA) does not affect the clinical response to adalimumab in a group of RA patients with the tumor necrosis factor (TNF) α-308 G/G promoter polymorphism

J. Aguillón, L. Salazar, H. Gatica, 2011, Clinical Rheumatology.

Weak CD4+ T-cell responses to citrullinated vimentin in rheumatoid arthritis patients carrying HLA-DR9 alleles

A. Escobar, J. Aguillón, O. Aravena, 2012, Rheumatology International.